Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
23.2M
-
Shares change
-
-2.56M
-
Total reported value, excl. options
-
$71.4M
-
Value change
-
-$5.37M
-
Put/Call ratio
-
0
-
Number of buys
-
44
-
Number of sells
-
-47
-
Price
-
$3.07
Significant Holders of Kyverna Therapeutics, Inc. - COM (KYTX) as of Q2 2025
105 filings reported holding KYTX - Kyverna Therapeutics, Inc. - COM as of Q2 2025.
Kyverna Therapeutics, Inc. - COM (KYTX) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.2M shares
.
Largest 10 shareholders include Vida Ventures Advisors, LLC (4.52M shares), GILEAD SCIENCES, INC. (4.13M shares), Bain Capital Life Sciences Investors, LLC (3.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.83M shares), VANGUARD GROUP INC (1.31M shares), Insight Holdings Group, LLC (989K shares), FRANKLIN RESOURCES INC (695K shares), MBB PUBLIC MARKETS I LLC (614K shares), Catalio Capital Management, LP (587K shares), and BlackRock, Inc. (533K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.